Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve the unaudited standalon and consolidated financial results of the Company for quarter and half year ended on Sep 30, 2026.